Hercules Capital Inc (HCXY) is a prominent publicly traded business development company focused on providing tailored financing solutions to growth-stage enterprises, predominantly in the life sciences and technology sectors. By utilizing its extensive industry expertise and strategic partnerships, Hercules delivers customized debt and equity financing that fosters innovation and value creation. With a strong emphasis on capital preservation and generating risk-adjusted returns, the company presents an attractive opportunity for institutional investors seeking diversified exposure to high-growth industries, backed by a robust investment strategy that successfully identifies and supports promising firms in a competitive market landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $190.88M |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently expanding